Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Innovus Pharmaceuticals CEO, Dr. Bassam Damaj, Featured on Wide World of Stocks Television (OTCQB:INNV)
PR: http://yhoo.it/1yR4J7o
Must Watch Interview: http://bit.ly/1tuLWNe
Innovus Pharmaceuticals CEO, Dr. Bassam Damaj, Featured on Wide World of Stocks Television (OTCQB:INNV)
PR: http://yhoo.it/1yR4J7o
Must Watch Interview: http://bit.ly/1tuLWNe
Innovus Pharmaceuticals CEO, Dr. Bassam Damaj, Featured on Wide World of Stocks Television (OTCQB:INNV)
PR: http://yhoo.it/1yR4J7o
Must Watch Interview: http://bit.ly/1tuLWNe
Did you know Innovus Pharmaceuticals Inc. (OTCQB:INNV) has a $1.34 price target? INNV is currently trading at $0.36. Huge potential upside!
INNV Alert: http://bit.ly/1pVdsjx
$1.34 price target: http://bit.ly/1riTVZD
INNV Huge News Out!: Innovus Announces the Acquisition of Vesele(R), A Safer Proprietary Oral Formualtion to Maximize Nitric Oxide's Beneficial Effects on Sexual Function and Brain Health - Innovus Pharmaceuticals (OTCQB:INNV)
http://finance.yahoo.com/news/innovus-announces-acquisition-vesele-r-100000531.html
INNV Huge News Out!: Innovus Announces the Acquisition of Vesele(R), A Safer Proprietary Oral Formualtion to Maximize Nitric Oxide's Beneficial Effects on Sexual Function and Brain Health - Innovus Pharmaceuticals (OTCQB:INNV)
http://finance.yahoo.com/news/innovus-announces-acquisition-vesele-r-100000531.html
INNV Huge News Out!: Innovus Announces the Acquisition of Vesele(R), A Safer Proprietary Oral Formualtion to Maximize Nitric Oxide's Beneficial Effects on Sexual Function and Brain Health - Innovus Pharmaceuticals (OTCQB:INNV)
http://finance.yahoo.com/news/innovus-announces-acquisition-vesele-r-100000531.html
L8TR, I noticed you inboxed me. Please email me at rtupp23@gmail.com. It will not let me msg you back on here. Thanks.
Penny Stock Circle's pick for tomorrow (Tuesday, Oct. 28th) is Innovus Pharmaceuticals Inc. (OTCQB:INNV). Welcome to the Winners Circle!
PSC INNV Alert!: http://bit.ly/1pSbqR9
Price Target = $1.34 (current price $0.40): http://bit.ly/1riTVZD
Breakout Confirmed (chart): http://bit.ly/1oSfQfS
INNV is on HIGH ALERT! Massive week ahead. $1.34 Price Target (current price is $0.38) Start your DD immediately. Innovus Pharmaceuticals Inc. (OTCQB:INNV)
WVC Newsletter: http://bit.ly/1rvFOAh
Price Target = $1.34 / share (currently trading at $0.38): http://bit.ly/1riTVZD
Major news: http://yhoo.it/1woTMJq
INNV is on HIGH ALERT! Massive week ahead. $1.34 Price Target (current price is $0.38) Start your DD immediately. Innovus Pharmaceuticals Inc. (OTCQB:INNV)
WVC Newsletter: http://bit.ly/1rvFOAh
Price Target = $1.34 / share (currently trading at $0.38): http://bit.ly/1riTVZD
Major news: http://yhoo.it/1woTMJq
INNV is on HIGH ALERT! Massive week ahead. $1.34 Price Target (current price is $0.38) Start your DD immediately. Innovus Pharmaceuticals Inc. (OTCQB:INNV)
WVC Newsletter: http://bit.ly/1rvFOAh
Price Target = $1.34 / share (currently trading at $0.38): http://bit.ly/1riTVZD
Major news: http://yhoo.it/1woTMJq
INNV Breaking Out! Could it go to its $1.34 Price Target? (It’s at $0.40)
The Wealthy Venture Capitalist
Wall Street opportunity for Main Street Investors
October 26th, 2014 – Issue #4
In this issue: Innovus Pharmaceuticals Inc. | Ticker: INNV | (US OTC Exchange)
http://eepurl.com/6Kgnj
INNV Breaking Out! Could it go to its $1.34 Price Target? (It’s at $0.40)
The Wealthy Venture Capitalist
Wall Street opportunity for Main Street Investors
October 26th, 2014 – Issue #4
In this issue: Innovus Pharmaceuticals Inc. | Ticker: INNV | (US OTC Exchange)
http://eepurl.com/6Kgnj
INNV Breaking Out! Could it go to its $1.34 Price Target? (It’s at $0.40)
The Wealthy Venture Capitalist
Wall Street opportunity for Main Street Investors
October 24th, 2014 – Issue #4
In this issue:
Innovus Pharmaceuticals Inc. | Ticker: INNV | (US OTC Exchange)
http://us8.campaign-archive1.com/?u=9ea1bd8e3a04bac704993687b&id=13efb9f7ba
INNV Breaking Out! Could it go to its $1.34 Price Target? (It’s at $0.40)
The Wealthy Venture Capitalist
Wall Street opportunity for Main Street Investors
October 24th, 2014 – Issue #4
In this issue:
Innovus Pharmaceuticals Inc. | Ticker: INNV | (US OTC Exchange)
http://us8.campaign-archive1.com/?u=9ea1bd8e3a04bac704993687b&id=13efb9f7ba
INNV up 33% today and climbing! Major announcement today. INNV is just getting started. Undervalued revenue producing company currently trading at $0.34 a share with a $1.34 price target! Innovus Pharmaceuticals (OTCQB:INNV)
News: http://yhoo.it/1woTMJq
See Thru Equity Research Report and Price Target: http://bit.ly/1riTVZD
INNV up 33% today and climbing! Major announcement today. INNV is just getting started. Undervalued revenue producing company currently trading at $0.34 a share with a $1.34 price target! Innovus Pharmaceuticals (OTCQB:INNV)
News: http://yhoo.it/1woTMJq
See Thru Equity Research Report and Price Target: http://bit.ly/1riTVZD
INNV up 15.7% today and climbing! Major announcement today. INNV is just getting started. Undervalued revenue producing company currently trading at $0.34 a share with a $1.34 price target! Innovus Pharmaceuticals (OTCQB:INNV)
News: http://yhoo.it/1woTMJq
See Thru Equity Research Report and Price Target: http://bit.ly/1riTVZD
INNV up 15.7% today and climbing! Major announcement today. INNV is just getting started. Undervalued revenue producing company currently trading at $0.34 a share with a $1.34 price target! Innovus Pharmaceuticals? (OTCQB:INNV)
News: http://yhoo.it/1woTMJq
See Thru Equity Research Report and Price Target: http://bit.ly/1riTVZD
INNV Huge News Out! Innovus Pharmaceuticals Receives Approval for the Expanded Label Indication for its Zestra(R) Product in Canada for the Temporary Increase of Desire/Arousal in Women with Female Sexual Interest/Arousal Disorder (OTCQB:INNV)
http://finance.yahoo.com/news/innovus-pharmaceuticals-receives-approval-expanded-100000118.html
INNV Huge News Out! Innovus Pharmaceuticals? Receives Approval for the Expanded Label Indication for its Zestra(R) Product in Canada for the Temporary Increase of Desire/Arousal in Women with Female Sexual Interest/Arousal Disorder (OTCQB:INNV)
http://finance.yahoo.com/news/innovus-pharmaceuticals-receives-approval-expanded-100000118.html
All Eyes on Innovus Pharmaceuticals Inc. (OTCQB:INNV) for tomorrow! INNV on HIGH ALERT! Put INNV on Your Trading Radar Right Now! http://bit.ly/1wnrFuf
INNV: Major Investment Opportunity with a potential 406% Return on Investment: Innovus Pharmaceuticals? Inc. (OTCQB:INNV) A revenue producing company in the pharmaceuticals sector has been given a $1.34 per share price target by SeeThruEquity. At the current market price ($0.265) this represents a potential 406% ROI! Start you Due Diligence now by visiting the links below.
PR: http://yhoo.it/1nFxOll
Research Report with Price Target: http://bit.ly/1riTVZD
Excellent Investment Opportunity! Revenue Producing Company! Innovus Pharmaceuticals Inc. (OTCQB:INNV)
INNV is currently experiencing a price correction after a strong September run up. This presents investors with an excellent opportunity to pick up undervalued shares in the market. Last time the stock corrected this low it made a run to $0.50 giving investors a potential 100%+ ROI in only a few short weeks. Always do your own DD before investing in any stock. Start your homework now with the DD links below. Please feel free to contact us with any questions about INNV.
Contact:
P: 1-866-865-2780
E: Tyler@Circadian-Group.com
Corporate Website: http://www.innovuspharma.com/
Corporate presentation: http://www.innovuspharma.com/corp_presentation.php
Fact Sheet: http://www.innovuspharma.com/fact-sheet.php
Company Press Releases: http://www.innovuspharma.com/media-relations.php
Products (Men's health, Woman's health, Pain relief): http://www.innovuspharma.com/products_OTC_mh.php#top
See Thru Equity research report PR and price target: http://finance.yahoo.com/news/seethruequity-initiates-research-coverage-innovus-130000402.html
15 page See Thru Equity research report with price target: http://media.wix.com/ugd/a15970_5d9782e0dc70430297af4cacad8eeddc.pdf
New CEO Video Interview: https://interlinked.com/groups/innovus-pharmaceuticals-inc-otcqb-innv/
Older videos: https://www.youtube.com/user/InnovusPharma
More media: http://www.innovuspharma.com/media-relations.php
Innovus Pharmaceuticals Inc. (OTCQB:INNV) Exclusive CEO Interview at FSXinterlinked Westlake Village
VIDEO: https://interlinked.com/groups/innovus-pharmaceuticals-inc-otcqb-innv/
Innovus Pharma is a leader in providing safe and effective non-prescription medicine and consumer care products to improve men and women’s sexual health and vitality.
Management with proven track record in commercialization, partnering, M&A and execution. Strong commercial pipeline generating revenue from multiple regions across the world.
Four commercial products and multiple SKUs in multiple markets
Currently anticipate adding 3 new products in 2014
Innovus Pharmaceuticals Inc. alerted by OtcStockPicks.net (OTCQB:INNV)
INNV (13G) 50Day Moving AVG Dragon Fly Doji SUPPORT! RARE
Email Alert: http://bit.ly/1oK4Xai
Innovus Pharmaceuticals? Inc. alerted by OtcStockPicks.net (OTCQB:INNV)
INNV (13G) 50Day Moving AVG Dragon Fly Doji SUPPORT! RARE
Email Alert: http://bit.ly/1oK4Xai
INNV News Out: Innovus Pharma Announces Podium Presentation at the World Meeting of Sexual Medicine, Discussing the Clinical Efficacy of Zestra(R) in Cancer Patients (OTCQB:INNV)
PR: http://yhoo.it/1vy24xu
SeeThruEquity Initiates Research Coverage on Innovus Pharmaceuticals?, Inc. with a Target Price of $1.34 (OTCQB:INNV)
http://finance.yahoo.com/news/seethruequity-initiates-research-coverage-innovus-130000402.html
INNV News Out! Innovus Pharmaceuticals? Signs License Agreement With Sothema Laboratories for Zestra(R) and Zestra Glide(R) in the Middle East (Excluding Lebanon and Israel), North Africa and West Africa (OTCQB:INNV)
- Innovus Eligible to Receive Upfront and Up to $171.25 Million U.S. in Sales Milestone Payments Plus Transfer Price
http://finance.yahoo.com/news/innovus-pharma-signs-license-agreement-101500068.html
INNV News Out! Innovus Pharmaceuticals? Signs License Agreement With Orimed Pharma for Zestra(R), EjectDelay(TM), Sensum+(TM) and Zestra Glide(R) in Canada (OTCQB:INNV)
- Innovus Eligible to Receive Up to $94.5 Million CAD in Upfront and Sales Milestone Payments Plus Double-Digit Tiered Royalties
http://finance.yahoo.com/news/innovus-pharma-signs-license-agreement-101500699.html
News Recap- GEI Global Energy Corporation? (OTCBB:GEIG), GreenGro Technologies, Inc.( GRNH)SEVEN & I HOLDINGS C(SVNDY), DBS Group Holdings Ltd. (ADR)( DBSDY ) http://bit.ly/1sguwqc
INNV News Out! Must read:
Innovus Pharmaceuticals? Signs Exclusive Marketing Sales and Distribution Agreement With Tramorgan Limited to Market and Distribute Sensum+(TM) in the United Kingdom (OTCQB:INNV)
-Innovus Pharma Eligible to Receive Up to $44 Million in Sales Milestone Payments Based on Tramorgan's Cumulative Sales Plus 50% Royalties on Its Net Sales
http://finance.yahoo.com/news/innovus-pharma-signs-exclusive-marketing-101500888.html
Check out the INNV Management Team. Dr. Bassam Damaj's last company Apricus Biosciences, Inc. traded on the Nasdaq. Is INNV poised to do the same? IMO it has a strong chance to do the same!
In 2009 Dr. Bassam Damaj joined Apricus Biosciences, Inc. at $0.37 per share.
In 2010 it was the 11th most liquid stock on the Nasdaq.
In 2011 the stock hit a record high of $5.50 per share.
in 2012 he resigned and the stock lost 30m dollars in market value.
During Dr. Damaj's tenure with Apricus the company's market value increase from $2.6m to $108m. That's an increase of over 4000%!
Coincidence? I think not. This is a serious management team and they are just getting started with INNV. $0.40 a share is an absolute steal. INNV IMO is undervalued and it won't take long before the market adjusts to reflects the company's true intrinsic value. This is an excellent stock to add to your long term holdings. JMO
Management Team: http://www.innovuspharma.com/management-team.php
INNV looking to break above $0.40. Need to close the day above $0.40. Keep INNV on your trade radar. Bullish.
AHII featured in the newsletter "The Wealthy Venture Capitalist" Shares of AHII currently up 9.09%.
The Wealthy Venture Capitalist: American Heritage International (OTC:AHII) & Super Nova Petroleum (CNSX:SNP | OTC:SNOVF) http://bit.ly/ZoeYE7
SNOVF featured in the newsletter "The Wealthy Venture Capitalist" Shares of SNOVF up as high as 50% today on record volume. Looks like a breakout here.
The Wealthy Venture Capitalist: American Heritage International (OTC:AHII) & Super Nova Petroleum (CNSX:SNP | OTC:SNOVF) http://bit.ly/ZoeYE7
Innovus Pharmaceuticals? (OTCQB:INNV): Click the link below to sign up to receive INNV Email Alerts. Stay up to date on INNV Press Releases, SEC Filings and Company Stock Information. Sign up today! http://investor.shareholder.com/innovuspharma/alerts.cfm?
Long Term Trade Alert! Great investment opportunity. MUST READ: Innovus Pharmaceuticals? (OTCQB:INNV) Corporate Presentation http://www.innovuspharma.com/pdf/CorporatePresentationJuly282014.pdf